famotidine has been researched along with Long QT Syndrome in 5 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the association of famotidine and acquired long QT syndrome has rarely been reported." | 7.72 | Famotidine and long QT syndrome. ( Hongo, RH; Kayser, SR; Lee, KW; Scheinman, MM; Tseng, ZH, 2004) |
| " However, the association of famotidine and acquired long QT syndrome has rarely been reported." | 3.72 | Famotidine and long QT syndrome. ( Hongo, RH; Kayser, SR; Lee, KW; Scheinman, MM; Tseng, ZH, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yun, J | 1 |
| Hwangbo, E | 1 |
| Lee, J | 1 |
| Chon, CR | 1 |
| Kim, PA | 1 |
| Jeong, IH | 1 |
| Park, M | 1 |
| Park, R | 1 |
| Kang, SJ | 1 |
| Choi, D | 1 |
| Sugiyama, A | 1 |
| Satoh, Y | 1 |
| Takahara, A | 1 |
| Nakamura, Y | 1 |
| Shimizu-Sasamata, M | 1 |
| Sato, S | 1 |
| Miyata, K | 1 |
| Hashimoto, K | 1 |
| Thompson, C | 1 |
| Tsiperfal, A | 1 |
| Lee, KW | 1 |
| Kayser, SR | 1 |
| Hongo, RH | 1 |
| Tseng, ZH | 1 |
| Scheinman, MM | 1 |
| Endo, T | 1 |
| Katoh, T | 1 |
| Kiuchi, K | 1 |
| Katsuta, Y | 1 |
| Shimizu, S | 1 |
| Takano, T | 1 |
5 other studies available for famotidine and Long QT Syndrome
| Article | Year |
|---|---|
Analysis of an ECG record database reveals QT interval prolongation potential of famotidine in a large Korean population.
Topics: Anti-Ulcer Agents; Databases, Factual; Electrocardiography; Famotidine; Female; HEK293 Cells; Humans | 2015 |
Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems.
Topics: Action Potentials; Animals; Cation Transport Proteins; Cell Line; DNA-Binding Proteins; Dogs; Electr | 2003 |
Why is the QT interval measurement so critical when evaluating an ECG rhythm?
Topics: Aged; Aged, 80 and over; Electrocardiography; Famotidine; Heart Conduction System; Histamine H2 Anta | 2003 |
Famotidine and long QT syndrome.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Electrocardiography; Famotidine; Heart Failure; Hi | 2004 |
Famotidine and acquired long QT syndrome.
Topics: Electrocardiography; Famotidine; Heart Conduction System; Histamine H2 Antagonists; Humans; Long QT | 2000 |